Patent · US Active

Combination of opioids and anticancer drugs for cancer treatment

US11052082B2 · kind B2 · utility

0Cited by

0References

28Claims

0Family size

Assignee

Universität Ulm · DE

Inventors

Claudia Friesen · Ulm, DE
Erich Miltner · Ulm, DE

Key dates

Filing date	Jun 5, 2018
Grant date	Jul 6, 2021
Priority date	—
Expiry date	Jun 5, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel strategies for the treatment of cancer patients based on a combination of an opioid receptor agonist and an anticancer compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.